Industry: Chemical & Material
Published Date: 2025-09-10
Pages: 80 Pages
Report ld: 4846855
Request Sample
Customized Report
Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size(US$)

CAGR 2025-2031
5.0%
Market Size,2031
USD 1,209
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pharmaceutical Grade Polyethylene Glycol (PEG) market competitiveness, regional economic performance, and supply chain configurations.
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.
1. Growth in the Biopharmaceutical Sector
PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.
Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.
2. Increasing Application in Drug Delivery Systems
Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.
Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.
4. Expansion in the Pharmaceutical Industry
Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.
Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.
5. Growing Focus on Sustainable and Bio-Based PEG
Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.
Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Grade Polyethylene Glycol (PEG) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mw (1000-10000) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Capsules in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharmaceutical Grade Polyethylene Glycol (PEG) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Product Scope
1.2 Pharmaceutical Grade Polyethylene Glycol (PEG) by Type
1.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Type (2020 & 2024 & 2031)
1.2.2 Mw (<1000)
1.2.3 Mw (1000-10000)
1.3 Pharmaceutical Grade Polyethylene Glycol (PEG) by Application
1.3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Liquids
1.3.5 Injectables
1.3.6 Topicals
1.3.7 Others
1.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size and Prospective (2020-2031)
2.4.4 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size and Prospective (2020-2031)
2.4.5 India Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price by Type (2020-2025)
3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Grade Polyethylene Glycol (PEG) Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price by Application (2020-2025)
4.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Grade Polyethylene Glycol (PEG) Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Grade Polyethylene Glycol (PEG) Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Polyethylene Glycol (PEG) as of 2024)
5.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company
6.1.1.1 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company
6.2.1.1 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company
6.3.1.1 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Grade Polyethylene Glycol (PEG) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company
6.4.1.1 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company (2020-2025)
6.4.1.2 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
6.4.2 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company
6.5.1.1 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Company (2020-2025)
6.5.1.2 India Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
6.5.2 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Type (2020-2025)
6.5.3 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Breakdown by Application (2020-2025)
6.5.4 India Pharmaceutical Grade Polyethylene Glycol (PEG) Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 BASF
7.1.1 BASF Company Information
7.1.2 BASF Business Overview
7.1.3 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.1.5 BASF Recent Development
7.2 Dow Chemical
7.2.1 Dow Chemical Company Information
7.2.2 Dow Chemical Business Overview
7.2.3 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.2.5 Dow Chemical Recent Development
7.3 Croda
7.3.1 Croda Company Information
7.3.2 Croda Business Overview
7.3.3 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.3.5 Croda Recent Development
7.4 Clariant
7.4.1 Clariant Company Information
7.4.2 Clariant Business Overview
7.4.3 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.4.5 Clariant Recent Development
7.5 Ineos
7.5.1 Ineos Company Information
7.5.2 Ineos Business Overview
7.5.3 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.5.5 Ineos Recent Development
7.6 India Glycols
7.6.1 India Glycols Company Information
7.6.2 India Glycols Business Overview
7.6.3 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.6.5 India Glycols Recent Development
7.7 Shandong Ruisheng
7.7.1 Shandong Ruisheng Company Information
7.7.2 Shandong Ruisheng Business Overview
7.7.3 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.7.5 Shandong Ruisheng Recent Development
7.8 Jiangxi Yipusheng
7.8.1 Jiangxi Yipusheng Company Information
7.8.2 Jiangxi Yipusheng Business Overview
7.8.3 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.8.5 Jiangxi Yipusheng Recent Development
7.9 Liaoning Huaxing Chemical
7.9.1 Liaoning Huaxing Chemical Company Information
7.9.2 Liaoning Huaxing Chemical Business Overview
7.9.3 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.9.5 Liaoning Huaxing Chemical Recent Development
7.10 Petronas Chemicals
7.10.1 Petronas Chemicals Company Information
7.10.2 Petronas Chemicals Business Overview
7.10.3 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
7.10.5 Petronas Chemicals Recent Development
8 Pharmaceutical Grade Polyethylene Glycol (PEG) Manufacturing Cost Analysis
8.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Grade Polyethylene Glycol (PEG)
8.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Distributors List
9.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Customers
10 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Dynamics
10.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Industry Trends
10.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Drivers
10.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Challenges
10.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 133
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 110
USD 3950.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-18
Pages: 92
USD 2900.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 119
USD 4350.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 98
USD 3950.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 136
USD 4900.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 133
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 136
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 110
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-18
Pages: 92
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 119
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 98
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now